Havn Life Archives

Psychedelics News

Havn Life

Industry

21 Sep 2022

HAVN Life Shutting Down?

Unfortunate news for investors in HAVN Life Sciences as it seems the company may be closing down its operations....

By Microdose NewsDesk

Events

15 Feb 2022

PsyCap Recap: HAVN Life Sciences

HAVN Life CEO Tim Moore and Spore Life CEO Michael Zavet joined Microdose’s Patrick Moher at the recent Psychedelic Capital event...

By Microdose

Press Releases

19 Mar 2021

Havn Life CEO to Present at Zooming With LD, a Leading Platform for Microcap Companies

CEO Tim Moore will appear on Tuesday, March 24th at 8:00 AM PT/ 11:00 AM ET Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Press Releases

16 Mar 2021

Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer

Pozar will lead sales, marketing, e-commerce and logistics for Havn Retail Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

22 Feb 2021

Havn Life announces DTC Eligibility of Its Common Shares in the United States

Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Press Releases

17 Feb 2021

Havn Life Announces Changes to Board Composition and Departure of Ms. Rasode

Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Press Releases

2 Feb 2021

Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc.

Havn Life to supply psychedelic compounds for clinical trials launched by neuroscience and technology leader HealthTech Connex Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Press Releases

26 Jan 2021

Havn Life Sciences Enters Definitive Agreement to Acquire Strategic Manufacturing & Packaging Facility for its Retail Division

The acquisition is intended to vertically integrate the Company’s retail manufacturing capabilities to support the growth of its nutraceutical division and deliver unique products to consumers....

By Microdose

Press Releases

22 Jan 2021

Havn Life Grants Stock Options and Restricted Share Rights

Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result